InCrowd

DECEMBER 14, 2022

I joined in 2015 and have never looked back. I marvel at what our clients do and the hope and relief they provide to patients struggling with difficult—sometimes life threatening—conditions. Trying to help customers do that in a more efficient and effective way really appealed to my desire to have a purpose in my work.

Marketing 147

Marketing Sales Pharma Healthcare 147

pharmaphorum

DECEMBER 15, 2022

Thousands more UK patients with idiopathic pulmonary fibrosis (IPF) will now be eligible for treatment with Boehringer Ingelheim’s Ofev, following new guidance from health technology assessment agency NICE. The NHS should make Ofev available within 90 days of the announcement by NICE, which means in mid-March 2023.

Pharmacology 106

Pharmacology Doctors Patients Medicine 106

European Pharmaceutical Review

JANUARY 25, 2023

The edited cells, exa-cel, are then infused back into the patient as part of an autologous hematopoietic stem cell transplant (HSCT). The elevation of HbF by exa-cel has the potential to reduce or eliminate painful and debilitating vaso-occlusive crises for patients with SCD and alleviate transfusion requirements for patients with TDT.

Medicine 111

Medicine Food and Drug Administration FDA Pharmaceutical 111

Medico Reach

AUGUST 18, 2022

Founder: Eric Lefkofsky Year of establishment: 2015 Headquarters: Chicago, Illinois. By leveraging deep research and employing efficient testing techniques, Tempus has managed to help thousands of patients find the correct clinical trials. In doing so, it helps to make each cancer patient’s story count. Flatiron Health.

Healthcare 98

Healthcare Healthcare Medical Doctors 98

European Pharmaceutical Review

JANUARY 30, 2023

The positive opinion from the CHMP brings us closer to providing a treatment choice to patients that offers increased convenience [through a decreased number of injections for patients who need 80mg/ml dosing] and a reduction in injection volume,” commented Florian Bieber, Global Head Biopharmaceuticals Development at Sandoz.

Food and Drug Administration 98

Food and Drug Administration Medicine Food Safety 98

World of DTC Marketing

DECEMBER 10, 2020

SUMMARY: (JAMA) The median drug wholesale list price (as defined by Average Wholesale Price) increased by 129% from 2010-2016, while median patient out-of-pocket costs increased by 53% and median insurance payments after rebates and discounts increased by 64%. Say goodbye to all the supposed goodwill.

Insurance 181

Insurance Pharma Manufacturing Retail 181

World of DTC Marketing

MAY 26, 2021

Today, Imbruvica is priced at $181,529 per year for a patient taking three pills per day, compared to $99,776 per year at launch. For a patient taking 3 tablets daily, the annual net price of Imbruvica increased from $72,587 in 2013 to $115,533 in 2017 (the last year for which AbbVie provided the Committee data).

Competition 180

Competition Marketing Government Patients 180

European Pharmaceutical Review

APRIL 18, 2023

It is estimated that 28 million patients suffer from chronic cough, with 10 million patients globally and six million in the US and European Union (EU) suffering from RCC for over a year, according to a 2015 study. Developing a promising P2X3 antagonist P2X3 is a validated target linked to cough reflex hypersensitisation.

Biopharma 98

Biopharma Sales Patients Medical 98

European Pharmaceutical Review

APRIL 29, 2024

This means that patients with the rare genetic bleeding disorder can produce FIX themselves instead of relying on regular intravenous infusions of FIX, which is the current standard of care, according to 2015 research highlighted by Pfizer. Pfizer licensed BEQVEZ from Spark Therapeutics in December 2014.

Food and Drug Administration 96

Food and Drug Administration Medicine FDA Food 96

European Pharmaceutical Review

NOVEMBER 22, 2022

“Delaying drug release and delivering oral dosage forms to the colon is challenging, so T21 offers a promising new option for ulcerative colitis patients by providing site-specific drug delivery and localised drug effect, mitigating potential side effects from systemic exposure.

Food and Drug Administration 111

Food and Drug Administration Side effects FDA Medicine 111

European Pharmaceutical Review

SEPTEMBER 20, 2023

2015; 7(5): 881-90. The post The benefits of mass spectrometry for expediting biologics to patients appeared first on European Pharmaceutical Review. Development of a quantitative mass spectrometry multi-attribute method for characterization, quality control testing and disposition of biologics. Zhang A, Chen Z, Li M, et al.

Patients 98

Patients Manufacturing Leads Safety 98

Pharmaceutical Technology

JULY 21, 2022

AI also speeds up the drug development process, which could translate into cheaper drugs for patients. Additionally, AI can improve patient wellbeing by automating health records, predicting illness, and enhancing treatment efficiency. Staff must be trained on processes and systems and patients made aware of security best practices.

Food and Drug Administration 98

Food and Drug Administration Government Pharma Healthcare 98

pharmaphorum

OCTOBER 28, 2022

In June, NHSE and NICE published details on the Innovative Medicines Fund, which will help improve patient access to cutting-edge medicines, with a particular focus on rare diseases, and ensure global pharmaceutical and biotech organisations continue to prioritise the UK as a launch destination.

Medicine 122

Medicine Management Marketing Leads 122

pharmaphorum

NOVEMBER 20, 2022

A Wall Street Journal investigation in 2015 discovered that most of the tests Theranos claimed to perform on its analyser were actually being performed by standard blood-testing machines. “I regret my failings with every cell of my body,” she continued.

FDA 122

FDA Patients Management Marketing 122

pharmaphorum

JANUARY 26, 2023

Yescarta – a CD19-directed genetically modified autologous T-cell immunotherapy investigated in the ZUMA-1 trial – is the first chimeric antigen receptor (CAR) T-cell therapy recommended for routine use on the NHS in England , meaning that for the first time eligible patients will be able to access CAR-T cell therapy in the long-term.

Engineering 96

Engineering Patients Consulting Healthcare 96

pharmaphorum

OCTOBER 31, 2022

The small-molecule PIKfyve inhibitor – called VRG50635 – has been administered to the first subject in the phase 1 trial involving healthy volunteers, according to the San Francisco-based biotech, which was founded in 2015 by Alice Zhang and Jason Chen. In preclinical studies VRG50635 has been shown to slow down the degeneration of neurons.

Pharma 136

Pharma Leads Medicine Marketing 136

pharmaphorum

SEPTEMBER 28, 2022

I think that in many cases with digital therapeutics, you also do have something of a recommendation to go with them, [with regards] to which patients is this going to work well for?” O’Leary said.

FDA 135

FDA Medical Healthcare Provider Engineering 135

pharmaphorum

OCTOBER 6, 2022

The strategy to build in cancer dates back to 2015, and has since gathered momentum with the purchase of the oncology businesses of Shire and Agios Pharma in 2018 and 2020, for $2.4 billion and $1.8 billion respectively, as well as smaller deals such as its takeover of Danish antibody specialist Symphogen.

Sales 98

Sales Pharma Government Medicine 98

Pharmaceutical Technology

JULY 15, 2022

Yet, data transparency must be foregrounded to foster patient trust, or AI’s potential in fertility treatments will not be realised. in 2015, and is expected to increase further to 16.5% This has the potential to increase the accessibility of IVF if companies pass on reductions in running costs to patients. in 2000 to 12.3%

Medical 105

Medical Prospecting Education Patients 105

pharmaphorum

NOVEMBER 25, 2022

Spectrum filed for accelerated approval of poziotinib as a second-line treatment for patients with HER2 exon 20 insertion-mutated, non-small cell lung cancer (NSCLC), but the FDA was unconvinced by the phase 2 data presented in support of the drug.

FDA 98

FDA Side effects Prescription Recruitment 98

Pharmaceutical Technology

APRIL 17, 2023

Also known as brexpiprazole, the FDA first approved Rexulti as a treatment for adults with schizophrenia and as an add-on treatment for adults with major depressive disorder in July 2015. The drug also comes with an increased risk of suicidal thoughts and behaviours in patients aged 24 and younger.

FDA 96

FDA Safety Food Patients 96

Infuse Medical

SEPTEMBER 9, 2024

billion from the 200 million seen in 2015. Surgeons can view 3D models of anatomical structures layered on the patient’s body with AR headsets including Microsoft HoloLens. ☛ Patient education: AR healthcare applications are not constrained to the operating theater but extend to the patient information.

Doctors 130

Doctors Healthcare Healthcare Medicine 130

Medico Reach

AUGUST 12, 2022

With medicare kits and reliable healthcare providers, the company makes patients the top priority. billion Company evaluation: $8 billion In operation since: 2015 Tempus integrates AI technology to find effective cancer treatments. Their primary focus is on patients suffering from osteoarthritis with no drug medication available.

Healthcare 98

Healthcare Healthcare Healthcare Provider Engineering 98

European Pharmaceutical Review

JANUARY 18, 2024

The company predicted this will be “driven by an increase in the patient share of dual orexin receptor antagonists (DORAs)”. Comparatively, in 2015, GlobalData’s research expected that sales of therapies for Gaucher disease will reach $1.16 percent from $3.2 billion in 2022 to $4.1 billion in 2032. percent between 2022 and 2032.

Marketing 98

Marketing Sales Pharmacology Pharma 98

Legacy MEDSearch

AUGUST 8, 2022

Prior to the actual surgery, the planning system assists surgeons in formulating personalized patient implant plans based on preoperative CT scan anatomical data as well as specific implant data. was established in China in 2015 and is a subsidiary of MicroPort Scientific Corporation. NaviBot is subsidiary of MicroPort MedBot.

Food and Drug Administration 98

Food and Drug Administration Recruitment Medical Food 98

pharmaphorum

JANUARY 9, 2023

is to acquire the 2015-established Amryt Pharma Plc. Chief executive officer of Chiesi Group , Marco Vecchia, said: “This addition of the Amryt portfolio, as well as their expertise, will help us on our journey to bring medicines to patients, no matter how rare their condition may be.”. in an all-cash transaction at $14.50

Pharma 98

Pharma Biopharma Management Medicine 98

European Pharmaceutical Review

DECEMBER 22, 2022

Founded in 2015, Tmunity was formed by early innovators in the cell therapy field to advance early-stage academic cell therapy research and innovation into the clinic. First patient given base-edited CAR T cells. The post Kite to buy Tmunity, expanding its CAR T pipeline appeared first on European Pharmaceutical Review.

Manufacturing 98

Manufacturing Engineering Pharmaceutical Patients 98

European Pharmaceutical Review

JANUARY 9, 2024

The development of AI in and its application to the production process are all going to lead us into a new era where drugs are safer, more effective, and focused on treating patients. 2015; 13:8-17. 2015; 12(10):931-934. IEEE J Biomed Health Inform. 2018; 22(5):1589-1604. Kourou K, Exarchos TP, Exarchos KP, et al. Eur J Radiol.

Pharmaceutical manufacturing 122

Pharmaceutical manufacturing Manufacturing Pharmaceutical Food and Drug Administration 122

pharmaphorum

NOVEMBER 9, 2022

If we look back just 70 years, the prognosis for patients with haemophilia was remarkably different to what it is today. Where once whole blood or plasma transfusions were needed, now patients can receive recombinant, long-acting treatments that enable them to lead a life closer to normal. Placing patient experiences at the centre.

Management 98

Management Patients Sales goal Medical 98

European Pharmaceutical Review

OCTOBER 7, 2022

Slow-release formulations were a popular choice for manufacturers, as these varieties reduce the traditional dosage frequency for patients, who only need to take these medications say, once a week. This is especially beneficial as a way of decreasing potential side effects.

Manufacturing 98

Manufacturing Marketing Side effects Transportation 98

European Pharmaceutical Review

JULY 7, 2022

He then had a one-year stint at Merck Research Laboratories as Director of Clinical Research for Clinical Hepatology before returning to Bristol Myers-Squibb from 2010-2015. ” Since September 2021, Dr Hughes has been Senior Vice President of Clinical Development and Translational Medicine at Vertex Pharmaceuticals, based in Boston.

Medical 98

Medical Medicine Pharmaceutical Leads 98

European Pharmaceutical Review

AUGUST 26, 2022

According to Moderna, the chemical modification avoids provoking an undesirable immune response when mRNA is introduced into the body and has been worked on by scientist at the company since 2010 and first validated by Moderna in human trials in 2015. ” But why sue now? .

Sales 98

Sales Medicine Marketing Government 98

pharmaphorum

AUGUST 8, 2022

Mark Doyle, co-founder of The Method and creator of the A Life in a Day programme, tells us about the immersive experience he and his team created that allows anyone to live the life of a type 2 diabetes patient for 24 hours. Becoming a diabetes patient. Becoming a diabetes patient.

Patients 52

Patients Healthcare Healthcare Pharma 52

Pharma Marketing Network

MARCH 25, 2022

Although the caregiver is seen as an extension of the patient and their role is not strictly defined, they are informal members of the front-line care team. Caregiver observations of the patient experience over the progression of the disease may inform the safety and efficacy of a particular therapeutic. Sunny White. February 2019.

Pharma 98

Pharma Education Training Transportation 98

European Pharmaceutical Review

JANUARY 24, 2023

At Parexel, Sandra held roles in Phase I project management and business development, before being promoted to a senior portfolio director in 2015. About Velocity Clinical Research Velocity Clinical Research helps biopharmaceutical and CRO customers find the right patients for their studies.

Key account management 98

Key account management Physicians Networking Management 98

pharmaphorum

AUGUST 17, 2022

At Sanofi, we are committed to bringing higher quality medicines to patients faster, empowered by our advanced AI drug discovery engine,” Frank Nestle, global head of research and chief scientific officer at Sanofi, said in a statement. In 2019 they struck a major deal with China’s Hansoh pharmaceuticals.

Medicine 97

Medicine Pharma Engineering Sales 97

pharmaphorum

NOVEMBER 6, 2017

The Cancer Vanguard is a bold initiative setup to take leadership in the delivery of the National Cancer Strategy – Achieving World-Class Cancer Outcomes published in 2015 with a key aim of designing and implementing new and increasingly patient centric models of care in Cancer that can benefit and be adopted by the wider national cancer system.

Medicine 52

Medicine Pharma Patients Leads 52